Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma

British Journal of Haematology

Volumn 107, Issue 3, 1999, Pages 648-655

  Cull, G ^a,c   Durrant, L ^b   Stainer, C ^a   Haynes, A ^a   Russell, N ^a  

^a School of Clinical Laboratory Sciences   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Dendritic cell; Idiotype; Myeloma; Vaccination

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN IDIOTYPE; IMMUNOGLOBULIN M;

ADULT; ANTIBODY RESPONSE; ARTICLE; CASE REPORT; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINATION;

EID: 0032731377     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01735.x     Document Type: Article

References (37)

1. Alexanian, R. & Dimopoulos, M. (1994) The treatment of multiple myeloma. New England Journal of Medicine, 330, 484-489.
2. Bennett, S.R., Carbone, F.R., Karamalis, F., Flavell, R.A., Miller, J. & Heath, W.R. (1998) Help for cytotoxic T-cell responses is mediated by CD40 signalling. Nature, 393, 478-480.
3. Bergenbrant, S., Osterborg, A., Holm, G., Mellstedt, H. & Lefvert, A.K. (1991) Anti-idiotypic antibodies in patients with monoclonal gammopathies: relation to the tumour load. British Journal of Haematology, 78, 66-70.
4. Brossart, P. & Bevan, M.J. (1997) Presentation of exogenous protein antigens on major histocompatibility complex class 1 molecules by dendritic cells: pathway of presentation and regulation by cytokines. Blood, 90, 1594-1599.
5. Celluzzi, C.M., Mayordomo. J.I., Storkus. W.J., Lotze, M.T. S Falo, L.D. (1996) Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumour immunity. Journal of Experimental Medicine, 183, 283-287.
6. Dabadghao, S., Bergenbrant, S., Anton, D., He, W., Holm, G. & Yi, Q. (1998) Anti-idiotypic T-cell activation in multiple myeloma induced by M-component fragments presented by dendritic cells. British Journal of Haematology, 100, 647-654.
7. Disis, M.L., Bernhard, H., Shiota, F.M., Hand, S.L., Gralow, J.R., Huseby, E.S., Gillis, S. & Cheever, M.A. (1996) Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood, 88, 202-210.
8. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky. H., Brose, K., Jackson, V, Hamada, H., Pardoll, D. & Mulligan, R.C. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proceedings of the National Academy of Sciences of the United States of America, 90, 3539-3543.
9. Fischer, H.G., Frosch, S., Reske, K. & Reske-Kunz, A.B. (1988) Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augment antigen presentation function. Journa] of Immunology, 141, 3882-3888.
10. + cells and apoptosis suppress T-cell functions in multiple myeloma. British Journal of Haematol;ogy. 100, 469-477.
11. Gabrilovidi, D.I., Corak, J., Ciernik, I.F., Kavanaugh, D. & Carbone, D.P. (1997) Decreased antigen presentation by dendritic cells in patients with breast cancer. Clinical Cancer Research, 3, 483-490.
12. Gabrilovich, D.I., Hen, H.L., Girgis, K.R., Cunningham, H.T., Meny, G.M., Nadaf, S., Kavanaugh, D. & Carbone, D.P. (1996) Production of vascular endothelial growth factor by human tumour inhibits the functional maturation of dendritic cells. Nature Medicine, 2, 1096-1103.
13. Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, G. & Levy, R. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Medicine, 2, 52-58.
14. King, C.A., Spellerberg, M.B., Zhu, D., Rice, J., Sabota, S.S., Thompsett, A.R., Hamblin, T.J., Radl. J. & Stevenson, F.K. (1998) DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma. Nature Medicine, 4, 1281-1286.
15. Kwak, L., Taub, D.D., Duffey. P.L., Bensinger, W.I., Bryant, E.M., Reynolds, C.W. & Longo, D.L. (1995) Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor. Lancet, 345, 1016-1020.
16. Lim, S.H., Bailey-Wood, R. & Burnett, A.K. (1998) Id-pulsed dendritic cell vaccination in multiple myeloma. Blood, 92, (Suppl. 1), 108a.
17. MacKenzic, M., Strang, G., Peshwa, M., Sopapan, J. & Valone, F. (1998) Phase I/II trial of immunotherapy with idiotype-loaded autologous dendritic cells (APC8020) for refractory multiple myeloma. Blood, 92, (Suppl. 1), 108a.
18. Massaia, M., Borrione, P., Attisano, C., Barral, P., Beggiatio, E., Montacchini, L., Blanchi, A., Boccadoro, M. & Pileri, A. (1995) Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood, 12, 3679-3687.
19. Mayordomo, J.I., Zorina, T., Storkus, W.J., Zitvogel, L., Cellzzi, C., Falo, D., Melief, C.J., Ildslad, S.T., Kast, W.M., Deleo, A.B. & Lotze, M.T. (1995) Bone-marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Medicine, 1, 1297-1302.
20. 27-35-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors. Cancer Research. 57, 5534-5541.
21. Nelson, E.L., Li, X., Hsu, E.J., Kwak, L.J., Levy, R., Clayberger, C. & Krensky, A.M. (1996) Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. Blood, 88, 580-589.
22. Nestle, F.O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G. & Schadendorf, D. (1998) Vaccination of melanoma patients with peptide-or tumour lysate-pulsed dendritic cells. Nature Medicine, 3, 328-332.
23. Osterborg, A., Yi, Q., Henriksson, L., Fagerberg, J., Bergenbrant, S., Jeddi-Tehrani, M., Ruden, I.L., Lefvert, A.K., Holm, G. & Mellstedt, H. (1998) Idiotype immunization combined with granulocyte-colony stimulating factor in myeloma patients induced type I major histocompatibility complex-restricted, CD8-and CD4-specific T-cell responses. Blood, 91, 2459-2466.
24. + T-helper and a T-killer cell. Nature, 393, 474-478.
25. Romani, N., Gruner, S., Brang, D., Kampgen. E., Lenz, A., Trockenbacher, B., Konwalinka, E., Fritsch, P.O., Steinman, R.M. & Schuler, G, (1994) Proliferating dendritic cell progenitor cells in human blood. Journal of Experimental Medicine, 180, 83-93.
26. Sallusto, F. & Lanzavecchia, A. (1994) Efficient prescription of soluble antigen by cultured human dendritic cells is maintained by grarulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumour necrosis factor α. Journal of Experimental Medicine, 179, 1109-1118.
27. San-Miguel, J.E. (1992) Lymphoid subsets and prognostic factors in multiple myeloma. British Journal of Haematology, 80, 305-310.
28. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. & Enk, A. (1997) Induction of tolerance by IL-10 treated dendritic cells. Journal of Immunology, 159, 4772-4780.
29. Steinman, R.M. (1991) The dendritic cell system and its role in immunogenicity. Annual Review of Immunology, 9, 271-296.
30. + hemopoietic progenitors. Blood, 87, 1292.
31. Thielemans, K., Rothbard, J.B., Levy, S. & Levy, R. (1985) Syngencic anti-idiotypic immune responses to a B cell lymphoma. Journal of Experimental Medicine, 162, 19-34.
32. + T cell responses against peptides derived from Ig heavy chain rearrangements in B-cell malignancies. Blood, 92, (Suppl. 1), 514a.
33. Villunger, A., Egle. A., Marschitz, B., Kos, M., Bock, G., Ludwig, H., Geley, S., Kofler, R. & Greil, R. (1997) Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. Blood, 90, 12-20.
34. Volker, L.R., Okada, C.Y., Liso, A., Benike, C.J., Stockerl-Goldstein, K.E., Engleman, E.G., Blume, K.G. & Levy, R. (1999) Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma: a feasibility study. Blood, 93, 2411-2419.
35. Wen, Y.J., Ling, M., Bailey-Wood, R. & Lim, S.H. (1998) Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma. Clinical Cancer Research, 4, 957-962.
36. + subsets. British Journal of Haematology, 96, 338-345.
37. Yi, Q., Osterborg, A., Bergenbrant, S., Mellstedt, H., Holm, G. & Lefvert, K. (199 5) Idiotype-reactive T-cell subsets and tumour load in monoclonal gammopathies. Blood, 86, 3043-3049.